BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, January 19, 2026
See today's BioWorld
Home
» Five NMEs approved in July; COVID-19 data is 17%
To read the full story,
subscribe
or
sign in
.
Five NMEs approved in July; COVID-19 data is 17%
Aug. 21, 2020
By
Karen Carey
The number of FDA approvals tracked by BioWorld have continued their steady incline, with a total of 129 logged through July, placing 2020 at a five-year high.
BioWorld
Analysis and data insight